The FDA approved Lenacapavir, the first twice-a-year injection to prevent HIV, marking a historic step in public health.

Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

Yeztugo (lenacapavir) will be the first option that gives people who need or want PrEP the option of injecting only twice a ...

The US Food and Drug Administration (FDA) has approved lenacapavir as a long-acting injectable drug to prevent HIV.

Hopes of ending the global HIV epidemic anytime soon are fading among health workers and scientists, who say new infections could increase for the first time in decades.

As Obergefell v Hodges turns 10 years, LGBTQ+ rights face renewed threats amid political shifts, impacting health care equity ...

To this day, the UN estimates that one person dies from AIDs every single minute - despite the fact that effective treatement ...

Discover how young healthcare innovators from Durban are transforming clinical trials and community health, earning accolades ...

While promising, a recent breakthrough in HIV research is not a “cure” or a “vaccine”, as several posts claim on social media ...